| Detailed information |
|---|
| CancerLivER ID | 2235 |
| Biomarker | SNHG20 |
| Biomarker Name/Symbol (given in Publication) | SNHG20 |
| Biomolecule | LncRNA |
| Subject | Human |
| Degree of Validity | Prognostic Biomarker for HCC patients and validated on independent dataset |
| Experimental Condition | HCC v/s Normal; associated with survival of patients |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Upregulated in HCC |
| Level of significance | p < 0.001 |
| Source | Tissue |
| PMID | 27053960 |
| Type of Biomarker | Prognostic |
| Pathway | NA |
| Cohort | In cohort 1, fresh HCC tissues and adjacent non-tumor tissues were collected from 49 HCC patients; cohort 2 has 144 HCC patients and cohort 3 is TCGA dataset contain 331 cases of HCC patients |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | Human HCC |
| Year of Publication | 2017 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |